Exploring the causal relationship between B lymphocytes and Parkinson's disease: a bidirectional, two-sample
Jia Song1, Yidan Qin1, Lin Wang1
1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, 130033, China.
Scientific Reports
|February 2, 2024
Summary
This study investigated the causal link between B cell traits and Parkinson's disease (PD) using Mendelian randomization. Certain B cell phenotypes were associated with increased PD risk, while one showed a protective effect, suggesting a role for B cells in PD pathogenesis.
Area of Science:
- Immunology
- Neuroscience
- Genetics
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with significant motor symptoms and socioeconomic impact.
- B lymphocytes are implicated in PD pathogenesis, but their causal role remains unclear.
Purpose of the Study:
- To investigate the potential causal associations between various B-cell immunological traits and Parkinson's disease.
- To explore the bidirectional causal relationship between B cells and PD using Mendelian randomization.
Main Methods:
- A two-sample bidirectional Mendelian randomization (MR) study was conducted.
- Genome-wide association study data from 482,730 European individuals were analyzed for 190 B-cell traits.
- Inverse-variance weighted (IVW) method was the primary analysis approach, with heterogeneity and pleiotropy analyses for validation.
Main Results:
- Five B-cell immunological phenotypes showed nominal association with PD (P < 0.05).
- Increased percentages of specific B cell subsets (e.g., IgD+CD38- B cells, CD20 on IgD-CD24- B cells) were identified as risk factors for PD.
- CD38 on Plasma Blast-Plasma Cells was found to be a protective factor against PD.
Conclusions:
- The study suggests a potential role for specific B-cell phenotypes in the pathogenesis of Parkinson's disease.
- While some associations were nominally significant, they did not withstand Bonferroni correction, indicating a need for further investigation.
- These findings may inform early identification strategies and the development of immunotherapies for PD.
Related Concept Videos
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Pedigree Analysis
84.3K
Overview
84.3K


